Bing

SEARCH HISTORY

Promacta, approved by the FDA in late 2008 and developed in partnership with Ligand Pharmaceuticals Inc <LGND.O, was once touted by Wall Street ... Shares of Glaxo closed up 0.08 percent at $35.40 on the New York Stock Exchange. Ligand shares …
Reuters · ByRansdell Pierson · 5/12/2010
Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m Today's Trade Alerts include: Boots & Coots International Well Control Inc. (Amex: WEL), Ligand Pharmaceuticals Inc. (Nasdaq: LGND), Penwest ...
istock Analyst · 8/4/2008
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them to a lean corporate cost structure.Its products address the ...
4 Traders · 8/18/2015
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a global license and supply agreement with Sanofi to utilize Captisol in the development and commercialization of SAR-125844, a …
Investors Business Daily · 7/30/2015
And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.
Minyanville · 9/27/2013
SAN DIEGO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (Poseida), a privately-held ... Finance and Strategy and Chief Financial Officer at Ligand Pharmaceuticals, Inc. (NASDAQ:LGND), a $2 billion market capitalization, profitable ...
CNN Money · 8/5/2015
Thank you for meeting with us over the past week at our respective headquarters. As discussed, funds we manage own common stock and stock equivalents equal to nearly 10% of Baxter’s common shares making us the Company’s largest shareholder.
SECFilings · 8/14/2015
Dow Jones component Merck & Co. Inc. (MRK) saw its stock move -0.79% to $57.97, representing a per-share move of $0.46, on volume of 9.69 million shares for Friday. Merck & Co. Inc. currently has a total float of 2.83 billion shares and moves n/a a day ...
Equities · 8/7/2015
So far this year the fund has held losses to 2.7%, which ranks in the top one-third of the group. Balkin recently shared four top stock picks – all less-than-familiar names. Franklin Covey has an attractive brand but a tiny market share, with revenue of ...
Barron's · 6/3/2014
Martin Shkreli doesn’t sit still ... On Feb. 15, Shkreli took to Twitter to announce, “Five executives at RTRX [Retrophin’s stock symbol] spent most of Friday night and this morning trying to get a non-RTRX drug to a dying kid in Venezuela.”
Bloomberg · 4/17/2014